Adding an international twist to the year's biggest patent story, Myriad has surrendered its BRCA patents in Australia, reports Genomics Law Report's Dan Vorhaus and John Conley. Several months ago, a group of plaintiffs in Australia filed a lawsuit against Myriad similar to the one filed in the US, arguing that the patents are invalid because genes can't be patented.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.